[1]
|
Chen, X., Zhang, X., Li, X. and Wang, Z. (2013) Who and what should we rely on in early diagnosis of IPF? European Respiratory Journal, 41, 249-250.
doi:10.1183/09031936.00142012
|
[2]
|
Nathan, S.D., Shlobin, O.A., Weir, N., Ahmad, S., Kaldjob, J.M., Battle, E., et al. (2011) Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest, 140, 221-229.
doi:10.1378/chest.10-2572
|
[3]
|
Raghu, G., Collard, H.R., Egan, J.J., Martinez, F.J., Behr, J., Brown, K.K., et al. (2011) An Official ATS/ERS/JRS/ ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. American Journal of Respiratory and Critical Care Medicine, 183, 788-824. doi:10.1164/rccm.2009-040GL
|
[4]
|
Behr, J. (2013) Evidence-based treatment strategies in idiopathic pulmonary fibrosis. European Respiratory Review, 22, 163-168. doi:10.1183/09059180.00001013
|
[5]
|
Spagnolo, P., Del Giovane, C., Luppi, F., Cerri, S., Balduzzi, S., Walters, E.H., et al. (2010) Non-steroid agents for idiopathic pulmonary fibrosis. Cochrane Database of Systematic Reviews, 9, Article ID: CD003134.
doi:10.1002/14651858.CD003134.pub2
|
[6]
|
Nobel, P.W., Abera, C., Bradford, W.Z., Costabel, U., Glassberg, M.K., Kardatzke, D., et al. (2011) Pifernidone in patients with idiopathic pulmonary fibrosis (CAPAC-ITY): Two randomised trials. Lancet, 377, 1760-1769.
doi:10.1016/S0140-6736(11)60405-4
|
[7]
|
Navaratnam, V., Fleming, K.M., West, J., Smith, C.J., Jenkins, R.G., Fogarty, A., et al. (2011) The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax, 66, 462-467. doi:10.1136/thx.2010.148031
|
[8]
|
Adamali, H.I. and Maher, T.M. (2012) Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Design, Development and Therapy, 6, 261-272.
doi:10.2147/DDDT.S29928
|
[9]
|
Weiss, D.J., Berberich, M.A., Borok, Z., Stripp, B.R., Gail, D.B., Kolls, J.K., et al. (2006) Adult stem cells, lung biology, and lung disease. NHLBI/Cystic Fibrosis Foundation Workshop. Proceedings of the American Thoracic Society, 3, 193-207.
doi:10.1513/pats.200601-013MS
|
[10]
|
Weiss, D.J., Kolls, J.K., Ortiz, L.A., Panoskaltsis-Mortari, A. and Prockop, D.J. (2008) Stem cells and cell therapies in lung biology and lung diseases. Proceedings of the American Thoracic Society, 5, 637-667.
doi:10.1513/pats.200804-037DW
|
[11]
|
Weiss, D.J., Bertoncello, I., Borok, Z., Kim, C., Panoskaltsis-Mortari, A., Reynolds, S., et al. (2011) Stem cells and cell therapies in lung biology and lung diseases. Proceedings of the American Thoracic Society, 8, 223-272.
doi:10.1513/pats.201012-071DW
|
[12]
|
Matthay, M.A., Thompson, B.T., Read, E.J., McKenna, D.H. Jr., Liu, K.D., Calfee, C.S., et al. (2010) Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest, 138, 965-972.
doi:10.1378/chest.10-0518
|
[13]
|
Lee, J.W., Fang, X., Gupta, N., Serikov, V. and Matthay, M.A. (2009) Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proceedings of the National Academy of Sciences of USA, 106, 16357-16362. doi:10.1073/pnas.0907996106
|
[14]
|
Ishizawa, K., Kubo, H., Yamada, M. Kobayashi, S., Numasaki, M., Ueda, S., et al. (2004) Bone marrow derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Letters, 556, 249-252.
doi:10.1016/S0014-5793(03)01399-1
|
[15]
|
Zhen, G., Liu, H., Gu, N., Zhang, H., Xu, Y. and Zhang, Z. (2008) Mesenchymal stem cells transplantation protects against rat pulmonary emphysema. Frontiers in Bioscience, 13, 3415-3422. doi:10.2741/2936
|
[16]
|
Schweitzer, K.S., Johnstone, B.H., Garrison, J., Rush, N.I., Cooper, S., Traktuev, D.O., et al. (2011) Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. American Journal of Respiratory and Critical Care Medicine, 183, 215-225.
doi:10.1164/rccm.201001-0126OC
|
[17]
|
Sueblinvong, V., Loi, R., Eisenhauer, P.L., Bernstein, I.M., Suratt, B.T., Spees, J.L., et al. (2008) Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. American Journal of Respiratory and Critical Care Medicine, 177, 701-711.
doi:10.1164/rccm.200706-859OC
|
[18]
|
Bonfield, T.L., Koloze, M., Lennon, D.P., Zuchowski, B., Yang, S.E. and Caplan, A.I. (2010) Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. American Journal of Physiology-Lung Cellular and Molecular Physiology, 299, L760-L770. doi:10.1152/ajplung.00182.2009
|
[19]
|
Ortiz, L.Z., Gambelli, F., McBride, C., Gaupp, D., Baddoo, M., Kaminski, N., et al. (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sciences of USA, 100, 8407-8411. doi:10.1073/pnas.1432929100
|
[20]
|
Tzouvelekis, A., Koliakos, G., Ntolios, P., Baira, I., Bouros, E., Oikonomou, A., et al. (2011) Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal. Journal of Translational Medicine, 9, 182.
doi:10.1186/1479-5876-9-182
|
[21]
|
Tzouvelekis, A., Paspaliaris, V., Koliakos, G., Ntolios, P., Oikonomou, A., Froudarakis, M., et al. (2011) A prospective, non randomized, clinical trial to study the safety and efficacy of the endobronchial autologous infusion of adipose-derived mesenchymal stem cells (ADMSCs) in patients with idiopathic pulmonary fibrosis (IPF). European Respiratory Journal, 176, 3s.
|
[22]
|
Gharaee-Kermani, M., Gyetko, M.R., Hu, B. and Phan, S.H. (2007) New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: A potential role for stem cells in the lung parenchyma and implications for therapy. Pharmaceutical Research, 24, 819-841.
doi:10.1007/s11095-006-9216-x
|
[23]
|
Tzouvelekis, A., Antoniadis, A. and Bouros, D. (2011) Stem cell therapy in pulmonary fibrosis. Current Opinion in Pulmonary Medicine, 17, 368-373.
doi:10.1097/MCP.0b013e328348744f
|
[24]
|
Toonkel, R.L., Hare, J.M., Matthay, M.A. and Glassberg, M.K. Mesenchymal stem cells and idiopathic pulmonary fibrosis: potential for clinical testing. (2013) American Journal of Respiratory and Critical Care Medicine, 188, 133-140. doi:10.1164/rccm.201207-1204PP
|
[25]
|
Giangreco, A., Reynolds, S.D. and Stripp, B.R. (2002) Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. American Journal of Pathology, 161, 173-182.
doi:10.1016/S0002-9440(10)64169-7
|
[26]
|
Hong, K.U., Reynolds, S.D., Watkins, S., Fuchs, E. and Stripp, B.R. (2004) Basal cells are a multipotent progenytor capable of renewing the bronchial epithelium. American Journal of Pathology, 164, 577-588.
doi:10.1016/S0002-9440(10)63147-1
|
[27]
|
Kim, C.F., Jackson, E.L., Woolfenden, A.E., et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121, 823-835.
doi:10.1016/j.cell.2005.03.032
|
[28]
|
Kajstura, J., Rota, M., Hall, S.R., Hosoda, T., D’Amario, D., Sanada, F., et al. (2011) Evidence for human lung stem cells. The New England Journal of Medicine, 364, 1795-1806. doi:10.1056/NEJMoa1101324
|
[29]
|
Olsson, F., Denham, M., Cole, T.J., Hooper, S.B. and Mollard, R. (2007) Deriving respiratory cell types from stem cells. Current Stem Cell Research & Therapy, 2, 197-208. doi:10.2174/157488807781696203
|
[30]
|
Gomperts, B.N. and Strieter, R.M. (2007) Stem cells and chronic lung disease. Annual Review of Medicine, 58, 285-298. doi:10.1146/annurev.med.58.081905.134954
|
[31]
|
Krause, D.S., Theise, N.D., Collector, M.I., Henegariu, O., Hwang, S., Gardner, R., et al. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 105, 369-377.
doi:10.1016/S0092-8674(01)00328-2
|
[32]
|
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
doi:10.1080/14653240600855905
|
[33]
|
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E. and Ringdén, O. (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Experimental Hematology, 31, 890-896. doi:10.1016/S0301-472X(03)00110-3
|
[34]
|
Brody, A.R., Salazar, K.D. and Lankford, S.M. (2010) Mesenchymal stem cells modulating lung injury. Proceedings of the American Thoracic Society, 7, 130-133.
doi:10.1513/pats.200908-091RM
|
[35]
|
Garcia-Gomez, I., Elvira, G., Zapata, G., Lamana, M.L., Ramirez, M., Castro, J.G., et al. (2010) Mesenchymal stem cells: Biological properties and clinical applications. Expert Opinion on Biological Therapy, 10, 1453-1468.
doi:10.1517/14712598.2010.519333
|
[36]
|
Sueblinvong, V., Loi, R., Eisenhauer, P.L., Bernstein, I.M., Suratt, B.T., Spees, J.L., et al. (2008) Derivation of lung epithelium from human cord blood-derived mesenchymal stem cells. American Journal of Respiratory and Critical Care Medicine, 177, 701-711.
doi:10.1164/rccm.200706-859OC
|
[37]
|
Newman, R.E., Yoo, D., LeRoux, M.A. and Danilkovitch-Miagkova, A. (2009) Treatment of inflammatory diseases with mesenchymal stem cells. Inflammation & Allergy—Drug Targets, 8, 110-123.
doi:10.2174/187152809788462635
|
[38]
|
Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C. and Westenfelder, C. (2005) Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. American Journal of Physiology—Renal Physiology, 289, F31-F42.
doi:10.1152/ajprenal.00007.2005
|
[39]
|
Miyahara, Y., Nagaya, N., Kataoka, M., Yanagawa, B., Tanaka, K., Hao, H., et al. (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12, 459-465.
doi:10.1038/nm1391
|
[40]
|
American Thoracic Society, European Respiratory Society (2002) American thoracic society/European respiretory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. American Journal of Respiratory and Critical Care Medicine, 165, 277-304. doi:10.1164/ajrccm.165.2.ats01
|
[41]
|
Selman, M., King Jr., T.E. and Pardo, A. (2001) Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Annals of Internal Medicine, 134, 136-151.
doi:10.7326/0003-4819-134-2-200101160-00015
|
[42]
|
Kalluri, R. and Neilson, E.G. (2003) Epithelial-mesenchymal transition and its implications for fibrosis. Journal of Clinical Investigation, 112, 1776-1784.
doi:10.1172/JCI200320530
|
[43]
|
Selman, M., Pardo, A. and Kaminshi, N. (2008) Idiopathic pulmonary fibrosis: Aberrant recapitulation of developmental programs? PLoS Medicine, 5, e62.
doi:10.1371/journal.pmed.0050062
|
[44]
|
Wuyts, W.A., Agostini, C., Antoniou, K.M., Bouros, D., Chambers, R.C., Cottin, V., et al. (2013) The pathogenesis of pulmonary fibrosis: A moving target. European Respiratory Journal, 41, 1207-1218.
doi:10.1183/09031936.00073012
|
[45]
|
Moore, B.B. and Hogaboam, C.M. (2008) Murine models of pulmonary fibrosis. American Journal of Physiology— Lung Cellular and Molecular Physiology, 294, L152L160. doi:10.1152/ajplung.00313.2007
|
[46]
|
Uhal, B.D. (2008) The role of apoptosis in pulmonary fibrosis. European Respiratory Review, 17, 138-144.
doi:10.1183/09059180.00010906
|
[47]
|
Sisson, T.H., Mendez, M., Choi, K., Subbotina, N., Courey, A., Cunningham, A., et al. (2010) Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 181, 254-263.
doi:10.1164/rccm.200810-1615OC
|
[48]
|
Chilosi, M., Doglioni, C., Murer, B. and Poletti, V. (2010) Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 27, 7-18.
|
[49]
|
Jun, D., Garat, C., West, J., Thorn, N., Chow, K., Cleaver, T., et al. (2011) The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cell, 29, 725-735. doi:10.1002/stem.604
|
[50]
|
Lee, S.H., Jang, A.S., Kim, Y.E., Cha, J.Y., Kim, T.H., Jung, S., et al. (2010) Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/ fibrosis. Respiratory Research, 8, 16.
doi:10.1186/1465-9921-11-16
|
[51]
|
Zhao, F., Zhang, Y.F., Liu, Y.G., Zhou, J.J., Li, Z.K., Wu, C.G., et al. (2008) Therapeutic effects of bone marrowderived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplantation Proceedings, 40, 1700-1705.
doi:10.1016/j.transproceed.2008.01.080
|
[52]
|
Wang, S., Qu, X. and Zhao, C. (2012) Clinical applications of mesenchymal stem cells. Journal of Hematology & Oncology, 5, 19. doi:10.1186/1756-8722-5-19
|
[53]
|
Kotton, D.N., Ma, B.Y., Cardoso, W.V., Sanderson, E.A., Summer, R.S., Williams, M.C., et al. (2001) Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development, 128, 5181-5188.
|
[54]
|
Spees, J.L., Pociask, D.A., Sullivan, D.E., Whitney, M.J., Lasky, J.A., Prockop, D.J., et al. (2007) Engraftment of bone marrow progenitor cells in a rat model of asbestosinduced pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 176, 385-394.
doi: 10.1164/rccm.200607-1004OC
|
[55]
|
Kumamoto, M., Nishiwaki, T., Matsuo, N., Kimura, H. and Matsushima, K. (2009) Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. European Respiratory Journal, 34, 740-748.
doi:10.1183/09031936.00128508
|
[56]
|
Moodley, Y., Ilancheran, S., Samuel, C., Vaghjiani, V., Atienza, D., Williams, E.D., et al. (2010) Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. American Journal of Respiratory and Critical Care Medicine, 182, 643-651.
doi:10.1164/rccm.201001-0014OC
|
[57]
|
Cargnoni, A., Gibelli, L., Tosini, A., Signoroni, P.B., Nassuato, C., Arienti, D., et al. (2009) Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplantation, 18, 405-422. doi:10.3727/096368909788809857
|
[58]
|
Rojas, M., Xu, J., Woods, C.R., Mora, A.L., Spears, W., Roman, J., et al. (2005) Bone-marrow-derived mesenchymal stem cells in repair of the injured lung. American Journal of Respiratory Cell and Molecular Biology, 33, 145-152. doi:10.1165/rcmb.2004-0330OC
|
[59]
|
Moodley, Y., Atienza, D., Manuelpillai, U., Samuel, C.S., Tchongue, J., Ilancheran, S., et al. (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. American Journal of Pathology, 175, 303-313. doi:10.2353/ajpath.2009.080629
|
[60]
|
Banerjee, E.R., Laflamme, M.A., Papayannopoulou, T., Kahn, M., Murry, C.E. and Henderson Jr., W.R. (2012) Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model. PLoS ONE, 7, e33165. doi:10.1371/journal.pone.0033165
|
[61]
|
Spitalieri, P., Quitadamo, M.C., Orlandi, A., Guerra, L., Giardina, E., Casavola, V., et al. (2012) Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells. European Respiratory Journal, 39, 446-457. doi:10.1183/09031936.00005511
|
[62]
|
Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., et al. (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277-2286.
doi:10.1016/j.jacc.2009.06.055
|
[63]
|
Hare, J.M., Fishman, J.E., Gerstenblith, G., DiFede Velazquez, D.L., Zambrano, J.P., Suncion, V.Y., et al. (2012) Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transcendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial. JAMA, 308, 2369-2379. doi:10.1001/jama.2012.25321
|
[64]
|
Weiss, D.J., Casaburi, R., Flannery, R., Leroux-Williams, M. and Tashkin, D.P. (2013) A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest, 143, 1590-1598. doi:10.1378/chest.12-2094
|
[65]
|
Chaudhary, N.I., Schnapp, A. and Park, J.E. (2006) Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model. American Journal of Respiratory and Critical Care Medicine, 173, 769-776.
doi:10.1164/rccm.200505-717OC
|
[66]
|
Maher, T.M. (2013) PROFILEing idiopathic pulmonary fibrosis: Rethinking biomarker discovery. European Respiratory Review, 22, 148-152.
doi:10.1183/09059180.00000913
|
[67]
|
Moeller, A., Ask, K., Warburton, D., Gauldie, J. and Kolb, M. (2008) The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? The International Journal of Biochemistry & Cell Biology, 40, 362-382.
doi:10.1016/j.biocel.2007.08.011
|
[68]
|
Borzone, G., Moreno, R., Urrea, R., Meneses, M., Oyarzun, M. and Lisboa, C. (2000) Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 163, 1648-1653.
doi:10.1164/ajrccm.163.7.2006132
|
[69]
|
Chua, F., Gauldie, J. and Laurent, G.J. (2005) Pulmonary fibrosis: Searching for model answers. American Journal of Respiratory Cell and Molecular Biology, 33, 9-13.
doi:10.1165/rcmb.2005-0062TR
|
[70]
|
Degryse, A.L., Tanjore, H., Xu, X.C., Polosukhin, V.V., Jones, B.R., McMahon, F.B., et al. (2010) Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. American Journal of Physiology—Lung Cellular and Molecular Physiology, 299, L442-L452. doi:10.1152/ajplung.00026.2010
|
[71]
|
International Society for Stem Cell Research, Guidelines for the clinical translation of stem cells.
http://www.isscr.org/home/publications/ClinTransGuide
|
[72]
|
Loebinger, M.R. and Janes, S.M. (2007) Stem cells for lung disease. Chest, 132, 279-285.
doi:10.1378/chest.06-2751
|
[73]
|
Price, A.P., England, K.A., Matson, A.M., Blazar, B.R. and Panoskaltsis-Mortari, A. (2010) Development of a decellularized lung bioreactor system for bioengineering the lung: The matrix reloaded. Tissue Engineering Part A, 16, 2581-2591. doi:10.1089/ten.tea.2009.0659
|
[74]
|
Ling, L., Nurcombe, V. and Cool, S.M. (2009) Wnt signaling controls the fate of mesenchymal stem cells. Gene, 433, 1-7. doi:10.1016/j.gene.2008.12.008
|
[75]
|
Walker, N., Badri, L., Wettlaufer, S., Flint, A., Sajjan, U., Krebsbach, P.H., et al. (2011) Resident tissue-specific mesenchymal progenitor cells contribute to fibrogenesis in human lung allografts. American Journal of Pathology, 178, 2461-2469. doi:10.1016/j.ajpath.2011.01.058
|
[76]
|
Foronjy, R.F. and Majka, S.M. (2012) The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: Understanding microenvironmental cues. Cells, 1, 874. doi:10.3390/cells1040874
|
[77]
|
Warburton, D., Perin, L., DeFilippo, R., Bellusci, S., Shi, W. and Driscoll, B. (2008) Stem/progenitor cells in lung development, injury repair, and regeneration. Proceedings of the American Thoracic Society, 5, 703-706.
doi:/10.1513/pats.200801-012AW
|
[78]
|
Grove, J.E., Lutzko, C., Priller, J., Henegariu, O., Theise, N.D., Kohn, D.B. et al. (2002) Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. American Journal of Respiratory Cell and Molecular Biology, 27, 645-651.
doi:10.1165/rcmb.2002-0056RC
|
[79]
|
Loi, R., Beckett, T., Goncz, K.K., Suratt, B.T. and Weiss, D.J. (2006) Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. American Journal of Respiratory and Critical Care Medicine, 173, 171-179. doi:10.1164/rccm.200502-309OC
|
[80]
|
Aguilar, S., Scotton, C.J., McNulty, K., Nye, E., Stamp, G., Laurent, G., et al. (2009) Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS ONE, 4, e8013.
doi:10.1371/journal.pone.0008013
|
[81]
|
Konigshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O.V., Jahn, A., et al. (2010) WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. The Journal of Clinical Investigation, 119, 772-787. doi:10.1172/JCI33950
|
[82]
|
Macchiarini, P., Jungebluth, P., Go, T., Asnaghi, M.A., Rees, L.E., Cogan, T.A., et al. (2008) Clinical transplantation of a tissue-engineered airway. Lancet, 372, 2023-2030. doi:10.1016/S0140-6736(08)61598-6
|
[83]
|
Andrade, C.F., Wong, A.P., Waddell, T.K., Keshavjee, S. and Liu, M. (2007) Cell-based tissue engineering for lung regeneration. American Journal of Physiology—Lung Cellular and Molecular Physiology, 292, 510-518.
doi:10.1152/ajplung.00175.2006
|
[84]
|
Yu, W., Fang, X., Ewald, A., Wong, K., Hunt, C.A., Werb, Z., et al. (2007) Formation of cysts by alveolar type II cells in three-dimensional culture reveals a novel mechanism for epithelial morphogenesis. Molecular Biology of the Cell, 18, 1693-1700.
doi:10.1091/mbc.E06-11-1052
|
[85]
|
Nichols, J.E. and Cortiella, J. (2008) Engineering of a complex organ: Progress toward development of a tissueengineered lung. Proceedings of the American Thoracic Society, 5, 723-730. doi:10.1513/pats.200802-022AW
|